Arkivum
Arkivum is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A prospective, post-authorisation long-term follow up trial of patients previously treated with imlifidase prior to kidney transplantation, including a non-comparative concurrent reference cohort
Sponsor Hansa Biopharma AB
- Start (EU)
- Latest update
- Estimated end
A Phase 3 open-label, controlled, randomised, multi-centre trial comparing imlifidase and standard-of-care with standard-of-care alone in the treatment of severe anti-GBM antibody disease (Goodpasture disease)
Sponsor Hansa Biopharma AB
- Start (EU)
- Latest update
- Estimated end
A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with positive crossmatch against a deceased donor prior to imlifidase treatment, including non-comparative registry and concurrent reference cohorts
Sponsor Hansa Biopharma AB
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Arkivum?
The 2026-10-09 snapshot links Arkivum to 3 distinct CTIS trials. Recorded services include Trial master file management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Arkivum?
The most frequently recorded therapeutic areas are Nephrology, Transplantation. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Arkivum conducted?
The linked trials record locations in 13 countries, including Austria, Belgium, Czechia, Germany, Spain. These are trial locations, not confirmed office locations or countries where Arkivum delivered services.
What can this page tell me about Arkivum's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Arkivum. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Arkivum Limited